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Abstract
Background: There is a large treatment gap for common mental disorders (CMD), with wide variation by world region.
This review identifies factors associated with formal health service utilisation for CMD in the general adult population, and
compares evidence from high-income countries (HIC) with that from low-and-middle-income countries (LMIC).
Methods: We searched MEDLINE, PsycINFO, EMBASE and Scopus in May 2016. Eligibility criteria were: published in
English, in peer-reviewed journals; using population-based samples; employing standardised CMD measures; measuring
use of formal health services for mental health reasons by people with CMD; testing the association between this
outcome and any other factor(s). Risk of bias was assessed using the adapted Mixed Methods Appraisal Tool. We
synthesised the results using “best fit framework synthesis”, with reference to the Andersen socio-behavioural model.
Results: Fifty two studies met inclusion criteria. 46 (88%) were from HIC.
Predisposing factors: There was evidence linking increased likelihood of service use with female gender; Caucasian ethnicity;
higher education levels; and being unmarried; although this was not consistent across all studies.
Need factors: There was consistent evidence of an association between service utilisation and self-evaluated health status;
duration of symptoms; disability; comorbidity; and panic symptoms. Associations with symptom severity were frequently but
less consistently reported.
Enabling factors: The evidence did not support an association with income or rural residence. Inconsistent evidence was
found for associations between unemployment or having health insurance and use of services.
There was a lack of research from LMIC and on contextual level factors.
Conclusion: In HIC, failure to seek treatment for CMD is associated with less disabling symptoms and lack of perceived need
for healthcare, consistent with suggestions that “treatment gap” statistics over-estimate unmet need for care as perceived by
the target population. Economic factors and urban/rural residence appear to have little effect on treatment-seeking rates.
Strategies to address potential healthcare inequities for men, ethnic minorities, the young and the elderly in HIC require
further evaluation. The generalisability of these findings beyond HIC is limited. Future research should examine factors
associated with health service utilisation for CMD in LMIC, and the effect of health systems and neighbourhood factors.
Trial registration: PROSPERO registration number: 42016046551.
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Background
Common mental disorders (CMD) comprise depressive dis-
orders and anxiety disorders, according to the World Health
Organisation’s definition [1], and are a leading cause of dis-
ability worldwide [2, 3]. Depressive disorders include major
depressive disorder and dysthymia, while anxiety disorders
include generalised anxiety disorder (GAD), panic disorder,
phobias, social anxiety disorder, obsessive-compulsive dis-
order (OCD) and post-traumatic stress disorder (PTSD).
More than 300 million people were estimated to suffer from
depression in 2015 (4.4% of the global population), with al-
most as many affected by anxiety disorders, although there is
substantial comorbidity between the two [1].
Despite evidence of effective treatments for CMD [4],
there is a large “treatment gap” for CMD globally, with
only 42–44% of those affected worldwide seeking
treatment for these symptoms from any medical or
professional service provider, including specialists and
non-specialists, in the public or private sectors [5]. This
proportion has been shown to be much lower in low-
and middle-income countries, with estimates of as little
as 5% seeking treatment, even when traditional providers
are also included [6–8].
Within the Global Mental Health literature, these sta-
tistics have been used to call for the scaling up of mental
health services in order to reduce the treatment gap [9–
14], on the assumption that meeting clinical criteria for
CMD indicates – or acts as a proxy for – a need for
treatment.
Access to health services has been conceptualised as
the “fit between the patient and the health care system”
[15]. Donabedian (1973) defines access as “a group of
factors that intervene between capacity to provide ser-
vices and actual provision or consumption of services”
[16]. Identifying those factors that are associated with
seeking treatment for CMD can help us to better under-
stand the reasons for the treatment gap, and inform ser-
vice planning to expand access to care.
The Andersen behavioural model of health service
utilisation [17] provides a useful framework to inform
analyses of factors that influence health service utilisa-
tion. The Andersen model is a sociological model of
health service utilisation that has been extensively ap-
plied [18, 19]. This model proposes that the use of
health services is affected by:
(a) one’s predisposition to seek help from health
services when needed (a product of socio-
demographic characteristics, attitudes and beliefs);
(b) one’s need for care (both objective measures and
subjective perceptions of one’s health needs); and
(c) the structural or enabling factors that facilitate or
impede service utilisation (such as financial
situation, health insurance and social support).
In later iterations of the model it was recognised that these
predisposing, enabling and need factors can operate at both
the individual level and the contextual level [20, 21].
A substantial body of evidence exists on the factors
that influence health service utilization for health condi-
tions such as HIV treatment and maternal health care
[22–24], and more recently, depression [25]. However,
the latter review included treatment-seeking by adoles-
cents and by specific sub-groups of the population, and
as such its results may not be generablisable to the gen-
eral adult population. Furthermore, since depressive and
anxiety disorders are closely related and frequently
co-occur [26, 27], with many individuals experiencing
mixed anxiety-depression disorders [28], we believe that
it is more appropriate when studying non-clinical popu-
lations to consider the larger construct of CMD rather
than separating these disorders, as has been argued else-
where [29–31]. To date, there has been no comprehen-
sive review of the factors associated with health service
utilisation for symptoms of CMDs in the general adult
population.
The aim of this review is to investigate factors associ-
ated with the use of health services for CMD symptoms,
in observational, population-based studies.
Specific objectives are:
(1) To identify factors associated with health service
utilisation for CMD among adults in the general
population, and to assess the quality and
consistency of evidence supporting an association
between each factor and health service utilisation
for CMD.
(2) To evaluate the evidence for these associations
from high-income countries (HIC) compared to
that from low- or middle-income countries
(LMIC).
Methods
The protocol for this study was registered with PROSPERO
(registration number 42016046551) [32].
Results are presented according to PRISMA (Preferred
Reporting Items for Systematic Reviews and Meta-Analyses)
guidelines (see Additional file 1).
Information sources and search strategy
We searched four databases; MEDLINE, PsycINFO,
EMBASE and Scopus. We combined two key concepts
(CMD and health service utilisation) using keywords
and subject headings in the respective databases.
Results were retrieved on 5th May 2016. The search
strategy can be found in the Additional file 2. We sup-
plemented the database search by hand searching and
reference searches. We only included articles published
in English.
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Eligibility criteria
Since the population of interest is the general adult
population, we included only population-based studies,
defined as community-based epidemiological studies
that are representative of the adult population. We ex-
cluded studies that focused only on specific
sub-populations such as veterans, students, or prisoners,
whose experiences may not be representative of the
wider population and warrant separate reviews.
The primary outcome measure of interest was any
contact with formal health services – including private,
public, generalist and specialist – for mental health rea-
sons (also referred to as “treatment-seeking”) by adults
aged 18 and above with CMD. Reflecting the definition
of the treatment gap, we focussed specifically on use of
services as a binary outcome – i.e. any versus no use –
rather than volume of treatment received or quality of
care.
To be eligible for inclusion, the study must have
tested the association between treatment seeking and
any other factors. We therefore included only quanti-
tative studies, published in peer-reviewed journals,
and excluded narrative reviews and commentaries.
We included only studies in which the analyses were
restricted to those individuals who either met diag-
nostic criteria or screened positive for CMD using a
standardised instrument.
For the purposes of this article, CMD is defined as
those ICD-10 (International Classification of Diseases
- 10th Revision) disorders measured by the Clinical
Interview Schedule - Revised [33] – often considered
the gold standard for measuring CMD [34, 35] –
namely, depressive disorders, generalised anxiety dis-
order, panic disorder, phobias, obsessive compulsive
disorder, and mixed anxiety-depression disorder.
We excluded papers that measured only intentions to
seek help, or perceived barriers to care, since multiple
studies have found that these are not closely correlated
with behaviour [36–40].
No restrictions were placed on geographic area or date
of publication. Table 1 provides full details of the inclu-
sion criteria applied.
Study selection
The first author completed title and abstract screening
for all references retrieved. Subsequently two researchers
(GME and DK) independently screened a random sam-
ple of 10% of the references, and inter-rater reliability
was calculated at 94%. Full texts were retrieved for all
studies included after the title/abstract screening. The
first author screened all full texts, while the second au-
thor (GME) screened a purposive sample of 10%. At
both stages, disagreements were resolved through
discussion.
We assessed the quality of the relevant evidence extracted
from the included studies using the Mixed-Method
Appraisal Tool (MMAT) [41], which has been shown to
be quick and reliable to apply [42]. Table 2 sets out
the criteria used. Extracted evidence for the purposes
of this review was rated as poor, fair, good or excel-
lent if 0–1, 2, 3 or 4 of these criteria were met, re-
spectively. These ratings are not intended to reflect
the study quality in relation to its own primary aims,
but only of the quality of the evidence that related to
this review.
Data extraction and synthesis
The following data were extracted for all papers that
were included in the full text search: study title, au-
thors, publication date and journal; country; study de-
sign; population; CMD measure; outcome (i.e. health
service utilisation) measure; and factors associated
with the outcome (including null associations). An as-
sociation was regarded as detected when it was asso-
ciated with the outcome in the most fully-adjusted
model presented, with a p-value of < 0.05. The corre-
sponding authors were contacted for clarification in
case of any ambiguities.
Due to the number of different factors investigated, and
heterogeneity in the measures used, it was not feasible to
attempt a meta-analysis of the effect of each factor. In-
stead, the “best fit” framework synthesis method [43] was
used to compare the fit of the data with an existing model
of factors affecting health service utilisation. This tech-
nique was originally developed for the synthesis of qualita-
tive research, but has since been applied to reviews of
quantitative and mixed methods studies [44, 45].
The first author extracted the data from each of the
included papers and coded these deductively using the
Andersen framework described above [17]. Any data that
did not fit any of the headings in the Andersen model
headings were to be coded separately under a new
theme in a subsequent inductive phase.
To avoid bias in the synthesis and interpretation of
results due to pre-conceived ideas about which factors
are associated with treatment-seeking, we created a
priori definitions with which to categorise the associa-
tions found for each factor. These definitions (sum-
marised in Table 3) were created for the purposes of
the current review, and are intended to be conservative.
No prior studies were found to guide the operatio-
nalisation of these definitions, and therefore the
cut-off points chosen are necessarily arbitrary. How-
ever, we have tried to be entirely transparent in how
these have been applied, and present the full findings
and quality ratings in the appendices provided so the
reader can examine how the evidence relates to the
conclusions drawn.
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Table 1 Inclusion and exclusion criteria applied
Include Exclude
Participants - Population-based studies, in which participants are randomly
sampled from a sampling frame that can be reasonably
expected to include the majority of the adult population
- Studies in which CMD is measured and analyses are
restricted to those who “screen positive” for CMD.a
- Any studies including people aged under 18 (unless these are
presented separately in analyses)
- Studies with exclusion criteria that would rule out a large
proportion of the adult population (e.g. over-55 s only, people
of a particular minority ethnic group only, women who have
recently given birth)
- Studies in which participants do not live in community settings
(e.g. prisoners, inpatients, residents of elderly care homes) or are
defined by their occupation (e.g. doctors, police officers, students)
- Studies in which all participants have used health services for
mental health reasons
- Studies that combine people with CMD and those with other
conditions and do not report results separately in analyses
- Ecological level studies in which CMD is not controlled at the
individual level (i.e. it’s not possible to tell whether the people
using services are the same individuals who have CMD)
- Studies that apply overly restrictive exclusion criteria for participants,
e.g. focussed solely on individuals with a specific comorbid condition,
or restricted to only specific ethnic groups
Design - Observational
- Quantitative or qualitative comparison of treatment-seekers
and non-treatment-seekers
- Cross-sectional or longitudinal
- Articles published in peer-reviewed journals only
- Reviews/commentaries/opinion pieces
- Conference abstracts/dissertations/book chapters
- Case studies that lack quantitative evaluation
Outcomes - Studies reporting on the use/non-use (as a binary variable) of
formal, face-to-face health services (either specialist or non-
specialist, public or private) for mental health reasons
- Timeframe in which service use is measured must be clearly
defined (e.g. past 12 months)
- Studies reporting on general health care use (i.e. including for
reasons other than mental health problems)
- Studies examining use of only one specific treatment type
(e.g. antidepressant use only, counselling only)
- Studies reporting on volume of treatment (i.e. number of visits to
a treatment provider), adherence to treatment or quality
of treatment
- Studies reporting on rates of detection or referral
- Studies reporting on theoretical access rather than actual use (e.g.
insurance coverage, being registered with a clinic)
- Studies reporting on the use of online or telephone-based services
- Studies examining the use of informal care (e.g. friends/family/
religious support) or complementary/alternative treatments (i.e.
those provided outside of the formal health sector)
- Studies reporting on willingness or intentions to use services, or
recommendations for service use in case of experiencing CMD
symptoms, with no measure of actual behaviour
- Studies that report participation in screening as the outcome rather
than active treatment-seeking or uptake of services post-screening
Correlates - Any factors that are correlated with the outcome of interest,
including (but not limited to):
• demographic factors
• health status (e.g. severity/disability/comorbid conditions etc.)
• distance/transport to services
• insurance coverage
• interventions
• specific symptoms
• behavioural/personality factors
• neighbourhood characteristics
• characteristics of the healthcare provider
• health systems factors
• stigma/attitudes towards services
- Studies reporting on the magnitude of the treatment gap, without
any correlates of treatment-seeking
- Studies that report predictors of service type (e.g. generalist vs.
specialist, pharmacological vs. psychological) rather than any vs.
no use
- Studies reporting barriers and facilitators to the use of health services,
without examining the association between these barriers and actual
treatment-seeking behaviour
Dates Any year of publication
Region Any country or region
aDefined as any of the following: depression, generalised anxiety disorder (GAD), panic disorder, phobias, obsessive compulsive disorder (OCD), or CMD not
otherwise specified
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Results
Search results
Figure 1 summarises the search process. After removing
duplicates, 10,331 papers were retrieved. Fifty-two papers
were found to meet the criteria at the full text screening
stage. Of these, eleven were cohort studies while forty-one
were cross-sectional.
Thirty-two (62%) of these studies reported data from
North America, nine (16%) from Europe, two (4%) from
Australasia, three (6%) from Africa, one (2%) from Asia, two
(4%) from Latin America and three (6%) used international
data from across world regions.
The study sizes varied considerably, from 56 partici-
pants to 18,972 participants with elevated levels of CMD
symptoms.
In terms of quality, evidence from one study was rated
as poor, evidence from 16 was classified as fair, evidence
from 20 was classified as good, and evidence from 15
studies was rated excellent. Additional file 3 presents the
characteristics of the included studies.
Factors associated with health service utilisation for CMD
Table 4 shows the number of studies that investigated
each of the factors in the Andersen model.
Compared to other factors, we identified the highest num-
ber of studies on the association between socio-demo-
graphic factors (classified according to the Andersen model
as “predisposing” factors) and treatment-seeking for CMD.
We also found a large number of studies that investigated
symptom severity, symptom profile and comorbidity
(termed “need” factors in the Andersen model) as correlates
of treatment-seeking. Fewer of the included studies exam-
ined enabling factors such as insurance, household wealth
and social support. There was a lack of published evidence
on some factors implicated by the Andersen model, such as
psychological factors (e.g. beliefs and attitudes, classified as
“predisposing” factors) and health systems factors (e.g. the
availability and accessibility of services).
Almost all of the factors identified were individual ra-
ther than contextual level factors. No factors were identi-
fied that could not be accommodated by the model.
Table 2 Operationalisation of quality appraisal criteria, based on the Mixed-Method Appraisal Tool (MMAT)
Criterion Definition Example
Appropriate
sampling strategy
Population-based sample using a sampling frame that
can reasonably be assumed to include the majority of
the non-institutionalised adult population. (Justification
of sample size was not included in this criterion since
none of the included studies justified their sample size
with reference to the research questions addressed in
this review.)
Meets criterion:
Simple random sample of households chosen from a government list of
residential addresses, then one resident aged > = 18 randomly chosen to
participate.
Doesn’t meet criterion:
Males and females sampled through separate means (males at
compulsory conscription, females at enrolment on the electoral register).
Sample
representative of
target population
Sample representative of non-institutionalised adult
population, with minimal exclusion criteria applied.
Meets criterion:
All adults eligible in urban area where study was conducted. Sample
representative of urban residents with regard to major socio-demographic
factors tested.
Doesn’t meet criterion:
Participants excluded due to age, ethnicity, chronicity of symptoms,
comorbid conditions etc.
Appropriate
measures used
Validated measure of CMD (either screening tool or
diagnostic instrument), timeframe for health service
utilisation limited and specified.
Meets criterion:
CIDI, AUDADIS-IV, CIS-R, SPIKE, PHQ-9, GAD-7, DIS, Burnam depression screener
12 month help-seeking from health services for MH reasons
Doesn’t meet criterion:
Self-defined depression/anxiety, prior receipt of diagnosis
Lifetime use of health services (due to limited accuracy of recall)
Acceptable
response rate
> 60% response rate for cross-sectional studies
> 60% response rate and < 30% attrition rate for
longitudinal studies
Meets criterion:
> 60% response rate across all study sites, or across all major groups
compared
Doesn’t meet criterion:
< 60% response rate overall, in some study sites, or for one gender
Table 3 Definitions used to grade consistency of evidence
when synthesising findings from included studies
Evidence level Criteria
Good evidence of an
association
≥75% of studies that investigated this factor
report an association, of which ≥2 (using
different datasets) are of good/excellent quality
Good evidence of no
association
< 25% of studies that investigated this factor
report an association, of which ≥2 (using
different datasets) are of good/excellent quality
Inconsistent evidence 25–75% of studies that investigated this factor
report an association, of which ≥2 (using
different datasets) are of good/excellent quality
Poor quality evidence
only
< 2 studies of good/excellent quality (using
different datasets) investigated the association
between this factor and treatment-seeking for CMD
Not examined No studies investigated the association between
this factor and treatment-seeking for CMD
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A summary of findings for each factor group is presented
below. For more detailed results see the Additional file 4.
Predisposing factors
Overall synthesis of findings on predisposing factors
As shown in Table 4, while several trends were identi-
fied, no predisposing factors were consistently found to
be associated with seeking treatment.
Factor-by-factor synthesis of evidence from included
studies General trends across studies.
Having sought mental health treatment previously
was generally associated with increased likelihood of
seeking treatment [46–48]. The relationship between
age and health service utilisation for CMD was com-
monly found to be hill-shaped, with middle-aged re-
spondents most likely to seek treatment [49–68].
Female gender was frequently found to be associated
with increased treatment-seeking [46, 47, 49–55, 57–
62, 64, 65, 67–77], as was being Caucasian, which rep-
resented the majority ethnic group in the context of
most of the included studies [46, 47, 49–51, 53, 55, 57–
60, 64, 68, 70, 78–87]. Several studies reported that
higher education levels were associated with health ser-
vice utilisation for CMD, although this was not found
across all studies [46, 47, 49–51, 53, 55, 57–65, 68, 70,
76, 77]. Being married was negatively associated with
treatment-seeking, though it was unclear whether this
is due to greater use of services by the never married or
by those who are separated or divorced group [46, 47,
49–51, 55, 57–59, 62, 64–68, 70, 73].
Findings related to other predisposing factors.
There was mixed evidence with regard to immigration
status [46, 48, 68, 73, 82, 88], change in marital status
[46, 47, 71], and personality factors [51, 61, 66, 74].
There was limited published evidence available on age of
onset, from just three studies, but the findings generally
indicated increased likelihood of seeking treatment with
later onset [46, 71, 77]. There was also a lack of pub-
lished evidence on the effect of stigma or other beliefs
and attitudes [66, 67].
Need factors
Overall synthesis of findings on need factors Need
factors were most consistently associated with the use of
health services for CMD symptoms across studies, as
seen in Table 4.
Factor-by-factor synthesis of evidence from included
studies Consistent findings.
Five factors were consistently found to be associated
with treatment-seeking across studies. These were self-
evaluated health status or healthcare needs [50, 53, 67,
68, 70, 74, 83, 86]; duration or chronicity of symptoms
[49, 66, 71]; disability or functioning [48, 51, 63, 65, 68,
73, 74, 76]; comorbid mental disorders [46, 49–52, 54,
59, 65, 66, 70, 71, 73, 76, 77, 89–91]; and panic symp-
toms [46, 51, 52, 71, 91].
General trends across studies.
Symptom severity was generally reported to be associated
with an increased likelihood of seeking treatment [50, 51,
53, 54, 58, 59, 61, 65, 67, 71, 73, 74, 76, 78, 79, 85].
Fig. 1 PRISMA flowchart showing selection of studies
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Findings related to other need factors.
There was mixed evidence for an association with sui-
cidality or specific CMD symptoms [46, 47, 51, 52, 59,
63, 66, 71, 76, 77, 85, 91, 92], substance use and
non-psychiatric conditions [47, 49–51, 53, 54, 57, 63, 65,
66, 68, 71, 73–75, 93–95] and adverse childhood events
[61, 74, 76, 77].
Enabling factors
Overall synthesis of findings on enabling factors As
indicated in Table 4, there was inconsistent evidence for
an association between treatment-seeking for CMD and
enabling factors.
Factor-by-factor synthesis of evidence from included
studies Consistent findings.
The studies included here did not support an associ-
ation between wealth or income and the use of health
services for CMD symptoms [47, 55, 58, 60, 62, 64, 65,
67, 68, 75].
General trends across studies.
Some studies indicated a positive association between
treatment-seeking and being in employment although
this was not found across all studies [50, 51, 58, 62, 65,
73, 75, 76]. Having health insurance was frequently, but
not consistently, reported to be correlated with health
service utilisation for CMD [47, 49, 50, 53, 60, 63, 68].
Findings related to other enabling factors.
There was mixed evidence with regard to social
support [50, 61, 66, 68, 75], and limited published
evidence available on the effect of having a regular
source of care [47, 48].
Contextual level factors
Overall synthesis of findings on contextual factors
Overall, limited published evidence was found testing
the association between contextual level factors and
health service utilisation for CMD.
Consistent findings.
The studies included here suggest that living in a rural
area is not associated with lower rates of treatment-seek-
ing [49, 51, 54, 55, 57, 65, 76].
Findings related to other contextual factors.
Few studies compared treatment-seeking between
countries or by geographic region within countries,
and those that did reported inconsistent findings [49,
57, 59, 78, 96, 97]. There was a dearth of published
evidence on the association between the health care
environment and utilisation of services for CMD, with
just one study on the effect of managed care [53],
one on perceived availability of services [50], and one
on perceived accessibility of services [67].
Comparison of evidence from LMIC and HIC
There was a clear discrepancy in the quantity of
research identified between high-income and low-and-
middle-income countries, with just six of the included
studies originating from LMIC and one international
study that included data from both HIC and LMIC
[93]. Five of the LMIC-only studies were from
middle-income countries; two from South Africa [64,
75], and one from Brazil [57], Mexico [69] and China
[67]. The only study from a low-income country was
from Ethiopia [62].
Evidence from three out of six LMIC studies was
rated as good or excellent. On average LMIC studies
were smaller than HIC studies, with a mean of 1742
participants with high CMD symptoms, compared to
3374 for HICs.
The LMIC studies identified predominantly reported on
the effect of predisposing factors, such as age, gender, and
education levels, and on measures of income or wealth.
There was insufficient published evidence from LMIC
to compare the factors associated with treatment-seeking
for CMD between HIC and LMIC.
Methodological limitations of included studies
The majority of studies used secondary datasets, which
limited the choice of variables to those that are typically
collected as part of multi-purpose epidemiological sur-
veys. The frequent use of cross-sectional data also limits
our ability to disentangle the direction of causation
when associations are found. The majority of studies
used multivariate logistic regression models for analysis.
The use of hierarchical models, or structural equation
modelling that explicitly recognises the potential interac-
tions between some of these factors, may have led to dif-
fering conclusions. Although several studies cited the
Andersen model to justify their choice of variables, there
seems to be little agreement as to how the model should
be operationalised and much heterogeneity in the mea-
sures used, making it difficult to compare the results
across studies. In particular, agreement is needed on
how variables indicating level of “need for care” should
be measured in the context of CMD, so that is it pos-
sible to control for this consistently when investigating
whether the use of health services is equitable. Finally,
many of the included studies did not correct for multiple
testing when investigating multiple associations simul-
taneously, and as such their findings should be viewed
as hypothesis-generating rather than hypothesis-testing.
Discussion
Principal findings
This review furthers our understanding of the treatment
gap for CMD by summarising patterns of treatment-seek-
ing. Need factors were most consistently found to be
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associated with treatment-seeking for CMD symptoms.
Enabling factors were not found to be consistently associ-
ated with treatment seeking for CMD. The evidence on
predisposing factors was inconsistent, although there was
weak evidence for an association with demographic factors,
specifically age, gender, ethnicity, education level and mari-
tal status. Finally, the current results suggest that urban or
rural residence is not associated with treatment-seeking.
With regard to the second objective, there was insufficient
published evidence from LMIC to draw any firm conclu-
sions about whether the factors associated with health ser-
vice utilisation for CMD differ from high-income countries.
Strengths and weaknesses
This review has several strengths: It employed a broad
search strategy, informed by previous reviews [22–24],
since the literature on this topic spans several disciplines
with varying terminology. It followed an a priori proto-
col, had screening verified at multiple stages by a second
researcher, and employed a widely recognised theoretical
framework to analyse the results. Compared to the most
recent review in this area [25], we searched a larger
number of databases in order to make the review as
comprehensive as possible.
This review adds to previous research by considering
the wider category of CMD rather than a single diagnostic
category, which several researchers have argued is a more
appropriate grouping for community and primary care
settings [26, 28–31]. It was also deliberately more liberal
in terms of its definition of CMD symptoms, since it is
generally accepted that CMD symptoms are better con-
ceptualised as a spectrum rather than a dichotomy be-
tween those who meet diagnostic criteria and those who
do not [27]. Since conducting full diagnostic interviews in
large population studies is often not feasible, it was hoped
that this broader definition would lead to the inclusion of
studies from a wider range of settings.
Other related reviews have been restricted to young
adults [98] or to one country only [99]. While the
results reported here are broadly consistent with the
findings of these reviews, this study extends previous re-
search by (a) comparing results across settings; (b)
including only population-based studies to ensure the
generalisability of findings; (c) examining a set of symp-
toms that typically present together in community set-
tings, making the results a stronger basis for informing
interventions at the population level; and (d) separating
service utilisation by adults from that of children or ado-
lescents, since in many countries services are delivered
separately for these two groups, and decisions regarding
treatment-seeking may follow different paths for minors
(defined here as those aged under 18).
However, the current review nonetheless has several
limitations that must be acknowledged. One is that it
was not possible to assess the power of each study to
detect an association, meaning that in studies where no
association was found with a given factor, this cannot be
interpreted with confidence to indicate a lack of associ-
ation rather than a lack of statistical power. Secondly, it
is possible that some studies in which this was not the
primary research question may have been erroneously
excluded if associations with treatment-seeking were not
reported in the title or abstract of the paper. This is
more likely to be the case when no associations are
found, leading to potential selection bias. For reasons of
feasibility, the search was restricted to studies published
in English.
We were not able to present data on the amount of
variance explained by the factors included in the studies
reviewed, since this was not reported in the majority of
these studies. Nor was it possible to discuss the con-
founding factors controlled for in every analysis, due to
the large number of studies included. To definitively as-
sess the causal effect of any one factor on treatment-
seeking for CMD a meta-analysis of that specific associ-
ation would be recommended; this was not the purpose
of the current review, which set out to summarise asso-
ciations, not to make causal claims.
The inclusion of multiple measures of CMD symptoms
also means that these will not be exactly comparable
across studies. Furthermore, when the quality of studies
was assessed, we considered the measure of CMD used
and the measure of treatment-seeking from the formal
health sector; however, due to the number of factors in-
vestigated it was not possible to assess the appropriateness
of measures used for each of these factors. Finally, as men-
tioned in the methods section, although the consistency of
evidence for each factor was graded according to
pre-defined criteria, other ways of operationalising levels
of evidence are possible, which could lead to more or less
conservative conclusions. Full details of all studies and the
criteria applied are presented in the appendices.
Comparison with previous literature
Our findings are consistent with previous research
pointing to need factors as the strongest determinants
of health service utilisation for mental disorders [100–
103]. This is also consistent with the finding from the
World Mental Health Surveys (WMHS) – which in-
cluded both LMICs and HICs and measured substance
use disorders and bipolar disorder as well as CMD –
that low perceived need was the most common reason
cited for not seeking treatment [104].
The same associations with female gender, middle age,
higher levels of education, and being unmarried were
found in the WMHS [8].
The fact that the evidence included in the current study
did not support an association with economic factors was
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surprising, given the evidence that socio-economic factors
affect the type of provider contacted [63, 68, 77], the qual-
ity of care received [63], adherence [105–109] and re-
sponse to treatment [110, 111]. However, a recent analysis
of WMHS data by Evans-Lacko et al. (2017) found that
differences in treatment rates in the WMHS by
socio-economic status were predominantly accounted for
by education rather than income [112].
Thus our findings on treatment-seeking for CMD are
largely in keeping with the largest international study of
mental disorders and service utilisation to date. The
WMHS did not investigate rural/urban residence, or any
of the other factors included in the Andersen model be-
sides those listed above.
Implications
Need factors, reflecting the extent to which CMD
symptoms interfere with people’s lives and whether out-
side help is needed, appear to be central to explaining
treatment-seeking behaviour. This suggests that many
of those who do not seek care from formal health
services for their CMD symptoms fail to do so not be-
cause of limited supply, but because of lack of demand
for services.
Whether meeting criteria for a disorder is a good indi-
cation of a “need for health services” is an ongoing
debate in the context of mental health care [113]. The
limited demand for interventions for CMD, compared to
the number of people who meet criteria for CMD, can
be conceptualised as a lack of education or awareness
about mental health issues, indicating a need for infor-
mation, education and communication campaigns. On
the other hand, it may be an indication that current
diagnostic categories are overly broad, and include a
large number of people who do not require formal med-
ical care. Patel (2014) has argued that current prevalence
estimates should not be regarded as the number of indi-
viduals in need of care, since a large proportion of these
individuals do not require formal interventions through
the health system [31]. Measures of functioning or qual-
ity of life may represent better indicators of “need for
care” than meeting diagnostic criteria (it is notable that
the latter concept was not investigated by any of the
studies included here).
Patel’s argument that increasing the supply of mental
health services will not alone make a substantial impact on
the treatment gap for mental disorders is supported by the
current findings that; (a) lack of perceived need is a major
determinant of failure to seek help from health services,
and (b) that enabling factors do not appear to be a major
determinant of treatment-seeking (discussed below). Many
individuals with less disabling symptoms are likely to view
informal support – such as social interventions in the com-
munity, or advice on self-care, listed at the bottom of the
World Health Organization (WHO) Service Organization
Pyramid [114] – as more appropriate for their needs. As
such, encouraging these individuals to seek care through
the health system may not be the best use of resources.
The lack of evidence for an association between enab-
ling factors and health service utilisation, even in set-
tings with weak public health systems, such as South
Africa, and without universal health coverage, like the
USA, was surprising. Of course, absence of evidence is
not proof of a lack of association, especially given that
the studies included here were not explicitly powered to
detect this relationship. There is also the potential for
information bias, given the sensitivity of financial topics,
since most studies used self-reported data.
However, the hypothesis that economic factors do
not play a major role in determining whether people
with CMD initially seek care from health services is
backed up by findings from Evans-Lacko et al. (2017)
[112], as well as Andrews et al. (2001), who found no
association at the ecological level with health spend-
ing or out-of-pocket costs [112, 115]. Furthermore,
Andrade et al. (2014) found that attitudinal barriers
(most commonly, wanting to handle the problem
alone) were reported much more often than structural
barriers (which are linked to enabling factors), with
the exception of severe cases. It is possible that the
inclusion in this review of individuals with milder
conditions, for whom low perceived need primarily
inhibits treatment-seeking, might be obscuring the
real impact of enabling factors such as cost and travel
distance on the sub-group with severe CMD, who are
most in need of care. Future research could usefully
examine the extent to which supply side factors such
as the availability, affordability and accessibility of
care affect service utilisation by those with the most
severe needs.
If equitable access to health care is defined as
equal utilisation by those with equal need for care
[116], then there is some evidence pointing to the
need to target underserved groups such as men, eth-
nic minority groups, the elderly and young adults, at
least in HIC. However, the extent to which need fac-
tors such as symptom severity and disability were
controlled in these analyses varied between studies,
so we cannot definitively rule out the possibility that
these differences can be explained by variability in
need for treatment.
Attempts to address these inequities have been made
in HIC through strategies such as enhancing cultural
competence in mental health services [117] and target-
ing underserved groups through social marketing [118],
with some success [119, 120]. Evaluations of these in-
terventions typically measure adherence/attrition, pa-
tient satisfaction or attitudes towards seeking care
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rather than treatment-seeking behaviour, so their effect-
iveness in reducing mental health care inequities is still
to be determined.
Regarding geographic location, some studies indicate
that this may affect the type of provider chosen and the
quality of care received [54, 121]. It is possible that the
initial decision of whether or not to seek treatment is
made independently of location of residence, but the
subsequent decision of where to seek treatment, and the
health system’s response, is influenced by geography.
This wants further investigation (see “Unanswered ques-
tions and future research”, below).
Finally, although it was not the topic of this review,
there was some evidence to suggest that the factors asso-
ciated with health service utilisation for CMD may vary
between the specialist and generalist sectors [64, 77, 87],
which has been highlighted in other studies [100, 112].
This warrants further investigation as it has important
implications for service planning. Thornicroft and Tan-
sella (2013) advocate a stepped care model of mental
health services, with the majority of services delivered
through primary care in low-resource settings [122].
However, it remains to be investigated which balance
leads to the most equitable use of services for CMD, and
whether some groups are more likely to seek treatment
through primary care in LMIC.
Unanswered questions and future research
This review identified three major gaps in our know-
ledge: Firstly, a lack of research from LMIC; secondly, a
dearth of research on contextual factors, particularly
health systems factors; and thirdly, an absence of studies
that are explicitly powered to test associations between
the factor of interest and treatment-seeking for CMD.
The first of these gaps directly relates to the second
objective of this review. Although we have drawn some
tentative conclusions above, the generalisability of these
findings to LMIC is questionable at best, since nearly
90% of the studies identified were from high-income
countries. In contrast, 85% of the world’s population is
expected to live in LMIC by 2030 [123], making this is
an extremely important omission.
Not only was there a noticeable lack of population-
based studies from LMIC, but those studies that were
identified were less consistent in their findings than those
from HICs. This may be in part due to the reduced statis-
tical power of studies from areas where treatment rates
are low, meaning that larger sample sizes are needed to
detect an association. More research is urgently needed in
LMIC – especially in those countries for which no
population-based studies were identified – to determine
whether the same factors are associated with treatment-
seeking for CMD in non-Western settings, using large
enough samples to detect an association.
Secondly, there was also a notable lack of published evi-
dence on several contextual factors, in particular health
systems factors that are likely to affect treatment-seeking.
This includes the availability of services, the geographical
accessibility of those services, and characteristics of ser-
vices such as opening times, which are central to several
models of access to health care [15, 124, 125]. This is a
crucial gap, as such evidence could usefully inform service
planning to expand access to care.
The extent to which distance affects treatment-seeking
has particular relevance to debates around decentralisa-
tion and integration of mental health care [126]. Facility-
based studies have pointed to distance and travel time as a
potentially important determinant of health service utilisa-
tion [127–131], which contrasts with the lack of evidence
supporting an association with urban/rural residence
found in this review. However, these studies cannot disen-
tangle geographic differences in prevalence from differ-
ences in treatment seeking behaviour. Furthermore,
unless they assess the use of all health facilities in a given
area – both public and private – it is not clear if distance
affects whether affected individuals seek any care, or if it
merely influences the choice of provider among those
who do decide to seek treatment. This review showed that
there is a lack of population-based data on the influence
of geographic accessibility on the uptake of health services
for CMD, with the exception of crude comparisons of
rural and urban areas, for which no association was found
with treatment-seeking.
Finally, none of the studies included here justified their
sample size with regard to the relationship between
treatment-seeking and the factors investigated. It is there-
fore possible that the lack of associations identified in some
of the studies included here are the result of
under-powered studies, rather than a genuine lack of asso-
ciation. To build the evidence base in this area and confirm
the hypotheses generated by the current review, future
studies should ensure that they have sufficient statistical
power to detect an association with the factors investigated.
Conclusions
This review found that the set of factors most consistently
associated with formal health service utilisation for CMD
among the adult population were need factors, with incon-
sistent evidence of an association with predisposing factors
– specifically demographic factors – and little evidence to
support an association with enabling factors. Health system
factors, such as the availability and accessibility of services,
are under-researched in population-based studies. Research
in low and middle-income countries is urgently needed to
enhance our understanding of treatment-seeking for CMD
in order to inform efforts to expand access to effective in-
terventions and increase health service utilisation for CMD
by those with greatest need for care.
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